4,201 results on '"mucopolysaccharidoses"'
Search Results
2. Hunter Outcome Survey (HOS) (HOS)
3. Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI
4. Longitudinal Study of Bone Disease in Children with Mucopolysaccharidoses (MPS) I, II, and VI
5. Study of Cannabidiol in Sanfilippo Syndrome
6. Open-label Study of Anakinra in MPS III
7. Mucopolysaccharidosis VII Disease Monitoring Program
8. A Study to Evaluate the Safety, Tolerability, PK and PD of Intracerebroventricular GC1123 in Patients with MPS Ⅱ
9. A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II) (COMPASS)
10. Gene Therapy with Modified Autologous Hematopoietic Stem Cells for Patients with Mucopolysaccharidosis Type II
11. ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program (ScreenPlus)
12. UCB Transplant of Inherited Metabolic Diseases with Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells (DUOC-01)
13. MPS II Immunophenotyping
14. A Study to Investigate the Efficacy and Safety of OTL-203 in Subjects With MPS-IH Compared With Standard of Care With Allogeneic HSCT (HURCULES)
15. Expanded Access to Mepsevii
16. Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A)
17. An Extension Study of JR-171-101 Study in Patients With MPS I
18. A Study of Elaprase in Children and Adults With Hunter Syndrome (Mucopolysaccharidosis II) in India
19. Natural History of Atypical Morquio A Disease
20. Efficacy and Safety of YW17 (Laronidase-CinnaGen) Compared to Aldurazyme® in MPS I Patients
21. A Long-term Follow-up Study of Patients With MPS IIIA Treated With ABO-102
22. A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)
23. A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of JWK008 in Patients With Mucopolysaccharidosis Type I
24. Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH
25. Long Term Follow-Up for RGX-111
26. An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB
27. A Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers
28. Natural History Study of Participants With Sanfilippo Syndrome Type IIIC (MPSIIIC)
29. Mucopolysaccharidosis I (MPS I) Registry
30. A Study of Potential Treatment-Responsive Biomarkers and Clinical Outcomes in Hunter Syndrome
31. An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007
32. LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
33. Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX (LTFU)
34. Non-invasive Functional Assessment and Pathogenesis of Morquio A (NIFAMA)
35. A Study of Tividenofusp Alfa (DNL310) in Pediatric Participants With Hunter Syndrome
36. Baby Detect : Genomic Newborn Screening
37. A Study of GC1111 in Hunter Syndrom Patients
38. Early Check: Expanded Screening in Newborns
39. ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I
40. An Extension Study of JR-141 in Patients With Mucopolysaccharidosis Type II
41. A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type II
42. A Multicenter, Multinational, Observational Morquio A Registry Study (MARS) (MARS)
43. Alterations in Hurler–Scheie Syndrome Revealed by Mass Spectrometry-Based Proteomics and Phosphoproteomics Analysis.
44. The Military–Civilian Partnership Quality Improvement Program Concept: A Process to Improve Data Collection and Outcomes Assessment.
45. "Mucopolysaccharidosis syndrome in a 9-Year-old boy: oral-dental management and diagnostic considerations": a case report.
46. Quality of Integration of Air Force Trauma Surgeons Within the Center for Sustainment of Trauma and Readiness Skills, Cincinnati: A Pilot Study.
47. 'Mucopolysaccharidosis syndrome in a 9-Year-old boy: oral-dental management and diagnostic considerations': a case report
48. A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants
49. A Study to Assess the Safety of Myozyme® and of Aldurazyme® in Male and Female Participants of Any Age Group With Pompe Disease or With Mucopolysaccharidosis Type I (MPS I) in a Home-care Setting (HomERT)
50. Gene Therapy With Modified Autologous Hematopoietic Stem Cells for Patients With Mucopolysaccharidosis Type IIIA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.